Platinum based chemotherapy in elderly patients with non-small cell lung carcinoma (NSCLC): Experience from an Indian tertiary cancer center.

被引：0
|
作者：
Sharma, Aparna
Khurana, Sachin
Pramanik, Raja
Kumar, Sunil
Pathy, Sushmita
Malik, Prabhat Singh
机构：
[1] All India Inst Med Sci, Dr BRA IRCH, Delhi, India
[2] All India Inst Med Sci, New Delhi, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e20528
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20528
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Erlotinib (E) in non small cell lung cancer (NSCLC) patients (pts) ≥75 years old with comorbidities (cM): Experience at a tertiary referral center.
    Syrigos, Konstantinos N.
    Sarris, Evangelos
    Strimpakos, Alexios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] Taxanes with platinum compounds in the treatment of non-small cell lung cancer (NSCLC) patients (PTS). Our experience
    Marenich, A
    Gorbounova, V
    Reutova, E
    Kozlov, D
    Breder, V
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 253 - 256
  • [43] Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients
    Perez-Ramirez, Cristina
    Canadas-Garre, Marisa
    Alnatsha, Ahmed
    Villar, Eduardo
    Ramon Delgado, Juan
    Jose Faus-Dader, Maria
    Angel Calleja-Hernandez, Miguel
    PHARMACOLOGICAL RESEARCH, 2016, 111 : 877 - 884
  • [44] Palliative chemotherapy (QT) and prognostic factors in elderly patients with advanced non-small Cell lung cancer (NSCLC)
    Zotano, AG
    Ariño, LP
    Saera, JM
    Abad, LP
    Lorenzo, JP
    Ortiz, AG
    Beveridge, RD
    Huerta, AS
    Salcedo, JM
    LUNG CANCER, 2005, 49 : S246 - S246
  • [45] Weekly Paclitaxel as Third Line Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
    Belloni, P.
    Cozzi, C.
    Zannier, F.
    Corradini, G.
    Candido, P.
    Della Torre, S.
    Toniolo, D.
    Fariciotti, A.
    Vismara, A.
    Bollina, R.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S538 - S538
  • [46] ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER - EXPERIENCE FROM TAIWAN
    Tseng, Yen-Han
    Wu, Yu-Chung
    Hsu, Han-Shui
    Hsu, Wen-Hu
    Chen, Yuh-Min
    RESPIROLOGY, 2018, 23 : 165 - 165
  • [47] Adjuvant Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Preoperative Chemotherapy
    Deng, L.
    Jiang, C.
    Perimbeti, S.
    Chen, H.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S234 - S234
  • [48] Gefitinib and celecoxib in patients with platinum refractory non-small cell lung cancer (NSCLC).
    Gadgeel, SM
    Shehadeh, NJ
    Ruckdeschel, JC
    Chaplen, RA
    Belzer, K
    Wozniak, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 639S - 639S
  • [49] Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC)
    Costa, Guilherme Jorge
    Godoy Fernandes, Ana Luisa
    Pereira, Jose Rodrigues
    Curtis, J. Randall
    Santoro, Ilka Lopes
    LUNG CANCER, 2006, 53 (02) : 171 - 176
  • [50] A slow disengagement from platinum-based chemotherapy for patients with advanced non-small cell lung cancer
    Ballas, MS
    Dennis, PA
    CANCER BIOLOGY & THERAPY, 2005, 4 (12) : 1316 - 1317
12345